Consistently, PCa patients with higher Gleason scores, more metastatic lymph nodes and biochemical recurrence exhibited a lower expression of B4GALT1 (Figure 7E, P < 0.05), and these patients had worse disease‐free survival (Figure 7F, P = 0.0093). The gene discussed is B4GALT1; the disease is posterior cortical atrophy.